Muth P, Metz R, Siems B, Bolten W W, Vergin H
Medical-Biological Development Heumann Pharma, Nürnberg, Germany.
J Chromatogr A. 1996 Apr 5;729(1-2):251-8. doi: 10.1016/0021-9673(95)00894-2.
A highly sensitive and selective HPLC method was developed and validated for the determination of nitrofurantoin in human plasma and urine. The method involves the liquid-liquid extraction of drug and internal standard from plasma with ethyl acetate followed by evaporation and reconstitution in mobile phase. Urine samples were simply diluted with purified water. UV detection was done at 370 nm. The limit of quantification for nitrofurantoin in plasma was 0.010 micrograms/ml. In urine nitrofurantoin could be quantified down to 0.380 microgram/ml. Linearity was proven over the whole calibration range in plasma (2.48-0.0100 microgram/ml) as well as in urine (187 micrograms/ml-0.380 microgram/ml). The method was validated according to Good Laboratory Practice guidelines and its suitability was demonstrated by analysis of samples from a pharmacokinetic study.
建立并验证了一种高灵敏度和选择性的高效液相色谱法,用于测定人血浆和尿液中的呋喃妥因。该方法包括用乙酸乙酯从血浆中液-液萃取药物和内标,然后蒸发并用流动相复溶。尿液样品只需用纯化水稀释。在370nm处进行紫外检测。血浆中呋喃妥因的定量限为0.010微克/毫升。在尿液中,呋喃妥因的定量下限可达0.380微克/毫升。在血浆(2.48-0.0100微克/毫升)和尿液(187微克/毫升-0.380微克/毫升)的整个校准范围内均证明了线性。该方法按照良好实验室规范指南进行了验证,并通过药代动力学研究样品的分析证明了其适用性。